NQO1 targeting prodrug triggers innate sensing to overcome checkpoint blockade resistance
Improper innate sensing within the tumor microenvironment limits immunotherapy success. Here, the authors show that targeting NQO1 triggers immunogenic innate sensing to reactivate T cells and overcome immune checkpoint blockade resistance.
Saved in:
Main Authors: | Xiaoguang Li, Zhida Liu, Anli Zhang, Chuanhui Han, Aijun Shen, Lingxiang Jiang, David A. Boothman, Jian Qiao, Yang Wang, Xiumei Huang, Yang-Xin Fu |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2019
|
Subjects: | |
Online Access: | https://doaj.org/article/f18e4e20985045188e6e4ba9bb61cc6d |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
by: Yong Liang, et al.
Published: (2018) -
CANCER IMMUNOTHERAPY BASED ON THE BLOCKADE OF IMMUNE CHECKPOINTS
by: A. V. Bogolyubova, et al.
Published: (2015) -
Metabolomic adaptations and correlates of survival to immune checkpoint blockade
by: Haoxin Li, et al.
Published: (2019) -
Predictors of responses to immune checkpoint blockade in advanced melanoma
by: N. Jacquelot, et al.
Published: (2017) -
Immune checkpoint blockade in the treatment of malignant tumor: current statue and future strategies
by: Wenwen Yang, et al.
Published: (2021)